Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005135
Filing Date
2025-02-21
Accepted
2025-02-21 17:20:10
Documents
1
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 form4-02212025_050206.html 4  
1 form4-02212025_050206.xml 4 5104
  Complete submission text file 0001415889-25-005135.txt   6620
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Golden Lee Scott (Reporting) CIK: 0001686217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 25653258